Developments in transgenic technology: applications for medicine

被引:22
作者
Hunter, CV
Tiley, LS
Sang, HM [1 ]
机构
[1] Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland
[2] Univ Cambridge, Ctr Vet Sci, Cambridge CB3 0ES, England
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1016/j.molmed.2005.04.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent advances in the efficiency of transgenic technology have important implications for medicine. The production of therapeutic proteins from animal bioreactors is well established and the first products are close to market. The genetic modification of pigs to improve their suitability as organ donors for xenotransplantation has been initiated, but many challenges remain. The use of transgenesis, in combination with the method of RNA interference to knock down gene expression, has been proposed as a method for making animals resistant to viral diseases, which could reduce the likelihood of transmission to humans. Here, the latest developments in transgenic technology and their applications relevant to medicine and human health will be discussed.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 68 条
  • [1] Recombinant protein expression for therapeutic applications
    Andersen, DC
    Krummen, L
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2002, 13 (02) : 117 - 123
  • [2] Retroviral vectors:: new applications for an old tool
    Barquinero, J
    Eixarch, H
    Pérez-Melgosa, M
    [J]. GENE THERAPY, 2004, 11 (Suppl 1) : S3 - S9
  • [3] Chance or necessity? Insertional mutagenesis in gene therapy and its consequences
    Baum, C
    von Kalle, C
    Staal, FJT
    Li, ZX
    Fehse, B
    Schmidt, M
    Weerkamp, F
    Karlsson, S
    Wagemaker, G
    Williams, DA
    [J]. MOLECULAR THERAPY, 2004, 9 (01) : 5 - 13
  • [4] Bhatia Prakash K., 1999, V64, P155
  • [5] The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins
    Bosze, Z
    Hiripi, L
    Carnwath, JW
    Niemann, H
    [J]. TRANSGENIC RESEARCH, 2003, 12 (05) : 541 - 553
  • [6] Alternative splicing of the ovine CFTR gene
    Broackes-Carter, FC
    Williams, SH
    Wong, PL
    Mouchel, N
    Harris, A
    [J]. MAMMALIAN GENOME, 2003, 14 (11) : 778 - 787
  • [7] The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants
    Bucher, E
    Hemmes, H
    de Haan, P
    Goldbach, R
    Prins, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 983 - 991
  • [8] Buchschacher GL, 2000, BLOOD, V95, P2499
  • [9] Characteristics of post-transcriptional gene silencing
    Chicas, A
    Macino, G
    [J]. EMBO REPORTS, 2001, 2 (11) : 992 - 996
  • [10] The mammary gland as a bioreactor: Expression, processing, and production of recombinant proteins
    Clark, AJ
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (03) : 337 - 350